Research and Markets offers ‘Outsourcing Clinical Development’
With the many challenges facing large pharmaceutical companies nowadays there is a need to reduce development costs by as much as 30-40%, while at the same time significantly shortening development cycle times. If outsourcing is to meet these challenges, new models of collaborative and cooperative working are needed.
Research and Markets now offers " Outsourcing Clinical Development", a guide that discusses new models and future clinical outsourcing strategy.
The new paper offers a detailed guide on negotiating the contract process, reviewing outsourcing performance and developing long-term strategic relationships. It also discusses dealing with contract research organizations (CROS) and working in low-cost environments.
With its perceptive insight, advice on long-term strategic direction and tools for immediate help, Outsourcing Clinical Development is a helpful guide for pharmaceutical companies and their CRO partners.
Image Source: www.freeimages.co.uk
2 Comments
Comments RSS
TrackBack Identifier URI
Leave a comment
In my opinion this is very serious problem. They should change clinical outsourcing strategy.
Comment by Viston on March 25, 2006 9:10 am
CRO market is growing and it is good for us :)
Comment by CRA (Ukraine) on September 24, 2008 12:25 pm